Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 36
17
Diseases
37
Unique genes
0.231
Avg. similarity score
Branchial arch abnormalities syndrome
Most-connected disease (11 links)
Disease
Searched: Liver cavernous hemangioma
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Liver cavernous hemangioma
Branchial arch abnormalities syndrome
Branchial cleft anomalies
Multiple malformations syndrome (bcahh)
Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome
Minor salivary gland adenocarcinoma
Vissers-bodmer syndrome
Congenital small ears
Hydatidiform mole
Intraocular medulloepithelioma
Spinal cord ependymoma
Vein of galen aneurysm
Agammaglobulinemia 6, autosomal recessive
Deafness, autosomal recessive 29
Hereditary neutrophilia
Holoprosencephaly 12 with or without pancreatic agenesis
Partial hydatidiform mole
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Branchial arch abnormalities syndrome | 11 | 11 | 1 |
| Branchial cleft anomalies | 11 | 11 | 1 |
| Multiple malformations syndrome (bcahh) | 11 | 11 | 1 |
| Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome | 9 | 9 | 1 |
| Liver cavernous hemangioma | 5 | 5 | 3 |
| Minor salivary gland adenocarcinoma | 5 | 5 | 5 |
| Vissers-bodmer syndrome | 5 | 5 | 3 |
| Congenital small ears | 4 | 4 | 5 |
| Hydatidiform mole | 4 | 4 | 12 |
| Intraocular medulloepithelioma | 4 | 4 | 4 |
| Spinal cord ependymoma | 4 | 4 | 7 |
| Vein of galen aneurysm | 4 | 4 | 6 |
| Agammaglobulinemia 6, autosomal recessive | 1 | 1 | 1 |
| Deafness, autosomal recessive 29 | 1 | 1 | 1 |
| Hereditary neutrophilia | 1 | 1 | 1 |
| Holoprosencephaly 12 with or without pancreatic agenesis | 1 | 1 | 1 |
| Partial hydatidiform mole | 1 | 1 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| KMT2D | 12 / 17 | Branchial arch abnormalities syndrome, Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome, Branchial cleft anomalies, Congenital small ears and 8 more |
| CD79B | 2 / 17 | Agammaglobulinemia 6, autosomal recessive, Minor salivary gland adenocarcinoma |
| CLDN14 | 2 / 17 | Deafness, autosomal recessive 29, Vein of galen aneurysm |
| CNOT1 | 2 / 17 | Holoprosencephaly 12 with or without pancreatic agenesis, Vissers-bodmer syndrome |
| CSF3R | 2 / 17 | Hereditary neutrophilia, Liver cavernous hemangioma |
| KHDC3L | 2 / 17 | Hydatidiform mole, Partial hydatidiform mole |
| NLRP7 | 2 / 17 | Hydatidiform mole, Partial hydatidiform mole |
| TP53 | 2 / 17 | Hydatidiform mole, Minor salivary gland adenocarcinoma |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Breast cancer | KEGG | 5 / 148 | 11.0× | 8.42e-5 | 1.66e-3 ✓ sig. |
| MicroRNAs in cancer | KEGG | 6 / 311 | 6.3× | 3.39e-4 | 4.95e-3 ✓ sig. |
| Neurotrophin signaling pathway | KEGG | 4 / 120 | 10.8× | 4.85e-4 | 6.53e-3 ✓ sig. |
| Endometrial cancer | KEGG | 3 / 59 | 16.5× | 7.77e-4 | 9.33e-3 ✓ sig. |
| Apoptosis | KEGG | 4 / 137 | 9.5× | 7.99e-4 | 9.55e-3 ✓ sig. |
| Pathways in cancer | KEGG | 7 / 533 | 4.3× | 1.05e-3 | 1.18e-2 ✓ sig. |
| Signaling by BRAF and RAF fusions | Reactome | 3 / 67 | 14.5× | 1.13e-3 | 1.24e-2 ✓ sig. |
| Hepatitis C | KEGG | 4 / 159 | 8.2× | 1.39e-3 | 1.45e-2 ✓ sig. |
| Hepatitis B | KEGG | 4 / 163 | 8.0× | 1.52e-3 | 1.56e-2 ✓ sig. |
| Pancreatic cancer | KEGG | 3 / 77 | 12.6× | 1.68e-3 | 1.68e-2 ✓ sig. |
| Chronic myeloid leukemia | KEGG | 3 / 77 | 12.6× | 1.68e-3 | 1.68e-2 ✓ sig. |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | Reactome | 2 / 20 | 32.5× | 1.69e-3 | 1.69e-2 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 4 / 170 | 7.6× | 1.78e-3 | 1.75e-2 ✓ sig. |
| Regulation of TP53 Activity through Acetylation | Reactome | 2 / 23 | 28.2× | 2.24e-3 | 2.07e-2 ✓ sig. |
| Colorectal cancer | KEGG | 3 / 87 | 11.2× | 2.39e-3 | 2.17e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cellular senescence | GO:0090398 | 5 / 57 | 44.3× | 8.93e-8 | 1.15e-5 ✓ sig. |
| regulation of hemopoiesis | GO:1903706 | 3 / 16 | 94.7× | 3.93e-6 | 2.61e-4 ✓ sig. |
| cardiac septum morphogenesis | GO:0060411 | 3 / 16 | 94.7× | 3.93e-6 | 2.61e-4 ✓ sig. |
| negative regulation of cell population proliferation | GO:0008285 | 7 / 444 | 8.0× | 2.27e-5 | 1.02e-3 ✓ sig. |
| regulation of developmental process | GO:0050793 | 3 / 32 | 47.3× | 3.41e-5 | 1.38e-3 ✓ sig. |
| nucleotide-excision repair | GO:0006289 | 3 / 42 | 36.1× | 7.78e-5 | 2.57e-3 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 10 / 1,208 | 4.2× | 8.56e-5 | 2.75e-3 ✓ sig. |
| negative regulation of Schwann cell proliferation | GO:0010626 | 2 / 8 | 126× | 1.06e-4 | 3.23e-3 ✓ sig. |
| chromosome organization | GO:0051276 | 3 / 51 | 29.7× | 1.39e-4 | 3.92e-3 ✓ sig. |
| response to UV-C | GO:0010225 | 2 / 10 | 101× | 1.70e-4 | 4.51e-3 ✓ sig. |
| regulation of protein localization to nucleus | GO:1900180 | 2 / 10 | 101× | 1.70e-4 | 4.51e-3 ✓ sig. |
| pattern specification process | GO:0007389 | 3 / 60 | 25.3× | 2.26e-4 | 5.54e-3 ✓ sig. |
| heterochromatin formation | GO:0031507 | 3 / 70 | 21.6× | 3.57e-4 | 7.59e-3 ✓ sig. |
| positive regulation of dendrite development | GO:1900006 | 2 / 16 | 63.1× | 4.50e-4 | 8.85e-3 ✓ sig. |
| positive regulation of cell population proliferation | GO:0008284 | 6 / 532 | 5.7× | 5.68e-4 | 1.03e-2 ✓ sig. |